October 2023 - Page 3 of 19

FridayOct 27, 2023 2:41 pm

QualityStocksNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Completes High-Definition Survey over PCH Ionic Clay Target IV Project Area

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) today announced that it has completed a high-definition lidar and orthophoto survey across an area of 1,702.50 hectares, which includes the company’s priority Ionic Clay Target IV project area in Goias, Brazil. Metro Cúbico Engenharia LTDA, which is headquartered in São Paulo and made up of a multidisciplinary team of professionals with more than 20 years of experience in various technological areas, was engaged by Appia to complete the survey. “Orthophotos are essential for the efficient management of our drill campaign as they provide high-resolution and accurate visual information with maximum detail,” said…

FridayOct 27, 2023 11:42 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Secures $5.2M in Private Placement and Preferred Investment Option Offerings

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs. The company today announced that it has closed its offering for the issuance and sale of 3,012,049 pre-funded warrants and preferred investment options to purchase up to an aggregate of 3,012,049 common shares, at a purchase price of $0.83 per pre-funded and associated preferred investment option, in a private placement priced at-the-market under Nasdaq rules. Per a previously announced definitive agreement with respect to certain of its outstanding preferred investment options issued in November 2022 and exercisable for 3,272,733…

FridayOct 27, 2023 10:42 am

QualityStocksNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Reports on Publication of Low-Dose Suramin for ASD Research

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company, announced that its groundbreaking research will be published in the “Annals of General Psychiatry,” an internationally recognized scientific psychiatry publication. The research was reported in a manuscript titled “Randomized clinical trial of low-dose suramin intravenous infusions for treatment of autism spectrum disorder,” which will be published by the psychiatry publication. Written by PaxMedica chief medical officer Dr. David Hough, MD, along with nine coauthors, the article reports on the potential of monthly suramin intravenous infusions as a safe and potentially efficacious treatment for the core symptoms of autism spectrum disorder (“ASD”). Coauthors of…

FridayOct 27, 2023 9:45 am

PaxMedica Inc.’s (NASDAQ: PXMD) CEO and Corporate Communications Chief Discuss Regulatory Strategy for Lead Drug Candidate and Future Plans in Recent Bell2Bell Podcast Interview

PaxMedica Chairman and CEO Howard Weisman participated in a recent Bell2Bell Podcast interview and was joined by Buzz Woods from Corporate Communications Weisman discussed the company’s strategy to seek FDA approval for Suramin as a treatment for Human African Trypanosomiasis (“HAT”) and plans for 2024 If PaxMedica is successful in getting approval in HAT, the company believes that could lead to the receipt of a Priority Review Voucher (“PRV”) The company hopes to monetize the PRV to raise funds that will support research and future trials investigating Suramin as a treatment for Autism Spectrum Disorder PaxMedica hopes to file an…

FridayOct 27, 2023 9:00 am

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Showcase Its Boutique End-to-End CDMO Services at the Premier CPHI Barcelona Event

Scinai will exhibit at the upcoming CPHI Barcelona event, showcasing its CDMO services The company expanded into the CDMO business earlier this year, operating under the banner Scinai Bioservices Scinai’s boutique end-to-end CDMO business division serves pharmaceutical, biotech, and alternative protein food tech companies with pilot and clinical process development and cGMP manufacturing Scinai intends to serve small biotech companies who require CDMO services with superior value compared to large, multinational CDMO companies Scinai will also exhibit at the upcoming BIO-Europe conference in Munich Scinai Immunotherapeutics (NASDAQ: SCNI), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products,…

ThursdayOct 26, 2023 3:35 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), QuantumBasel Announce Two-Year Agreement Extension to Fuel Quantum Commercial Adoption

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services as well as the world’s first commercial supplier of quantum computers, has extended its relationship with QuantumBasel. In addition, according to the announcement, D-Wave is planning to open a European office on the QuantumBasel campus to support the companies’ collaboration in fast tracking the commercialization of quantum computing in the region and facilitating increased development of near-term quantum applications for businesses, governments and researchers. QuantumBasel is Switzerland’s first quantum hub for commercial use embedded in the uptownBasel innovation campus, which serves as a global hub for Industry…

ThursdayOct 26, 2023 2:42 pm

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Expands Leadership Team, Eyes Bright Future

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in the development and support of digital assets and SEC-registered security tokens, previously announced the release of its new company mark and logo, as well as a significant transition in leadership by welcoming Brian J. Esposito as its new chief executive officer. As a renowned entrepreneur and business leader, Esposito brings to the company a proven track record of driving growth and innovation. “It is with great pleasure to announce that after 7 years my search for the right CEO to take this company forward has finally ended. It…

ThursdayOct 26, 2023 2:30 pm

GolfLync Inc. Unveils Exciting Updates to Enhance Your Golfing Experience

GolfLync, the leading social networking platform for golfers, is thrilled to announce a major update to its app, bringing a host of new features members will enjoy! Travel Mode: Play Golf Anywhere, AnytimeGolf and travel often go hand in hand, and GolfLync recognizes this synergy. The new Travel Mode allows members to change their location and seamlessly plan games, discover clubs, and connect with players in the area they are traveling to. Whether you're on a business trip, vacation, or simply exploring new golf courses, GolfLync makes it easy to find games and like-minded golfers across the country. With Travel…

ThursdayOct 26, 2023 2:29 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Clearing Path to Submit NDA for PAX-101

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company, today announced the completion of a type-B meeting with the FDA. During the live meeting, the company discussed positive results of the recent data from its PAX-HAT-301 study of suramin in stage one human African sleeping sickness caused by trypanosoma brucei rhodesiense, a rare and fatal parasitic disease if left untreated. According to the announcement, PaxMedica received constructive feedback that will aid in the completion of the remaining work necessary to file a New Drug Application (“NDA”) expected in the second half of 2024. “This is an important turning point for our young…

ThursdayOct 26, 2023 1:00 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Request to Continue Listing Is Granted by NASDAQ Hearings Panel

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was notified by the NASDAQ Hearings Panel that its request to continue listing on the NASDAQ capital market has been granted with two conditions. Those conditions call for the company to maintain a closing bid price of $1 per share for 20 consecutive trading sessions on or before Jan. 22, 2024, and hold an annual shareholder meeting on or before March 8, 2024. According to the announcement, the company held a meeting on Aug. 3, 2023, where proposals were approved by shareholders, but shareholders did not have an opportunity to…

Site Search

Company Search

Month: October 2023